(MedPage Today) -- The FDA has accepted Sanofi's new drug application for an upgraded formulation of its insulin glargine (Lantus), which is set to come off patent next year. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment